Robotic thymectomy in patients with myasthenia gravis: Neurological and surgical outcomes

European Journal of Cardio-thoracic Surgery

Volumn 48, Issue 1, 2015, Pages 40-45

  Keijzers, Marlies ^a   De baets, Marc ^b   Hochstenbag, Monique ^a   Abdul hamid, Myrurgia ^a   Zur hausen, Axel ^a   Van der linden, Marcel ^a   Kuks, Jan ^d   Verschuuren, Jan ^e   Kessels, Fons ^a   Dingemans, Anne Marie C ^a   Maessen, Jos ^a,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Minimally invasive surgery; Myasthenia gravis; Robotic thymectomy

Indexed keywords

PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CORTICOSTEROID THERAPY; CYST; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HISTOLOGY; HOSPITALIZATION; HUMAN; LIPOMA; LYMPHOID HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REMISSION; ROBOTIC THYMECTOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE; THYMECTOMY; THYMOMA; ADVERSE EFFECTS; LENGTH OF STAY; MIDDLE AGED; OPERATION DURATION; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; ROBOTIC SURGICAL PROCEDURE; THYMUS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; OPERATIVE TIME; RETROSPECTIVE STUDIES; ROBOTIC SURGICAL PROCEDURES; THYMECTOMY; THYMUS GLAND; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84936857058     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezu352     Document Type: Article

References (24)

1. McGrogan A, Sneddon S, de Vries CS. The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiology 2010;34:171-83.
2. Hohlfeld R, Wekerle H. Reflections on the 'intrathymic pathogenesis' of myasthenia gravis. J Neuroimmunol 2008;201-202:21-7.
3. Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Strobel P. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 2013;12:875-84.
4. Schumachter E, Roth J. Thymektomie bei einem Fall von Morbus Basedowi mit Myasthnie. Grenzgeb d Med u Chir 1912;25:746-65.
5. Blalock A. Thymectomy in the treatment of myasthenia gravis: report of twenty cases. J Thorac Surg 1944;13:316-39.
6. Diaz-Manera J, Rojas Garcia R, Illa I. Treatment strategies for myasthenia gravis: an update. Expert Opin Pharmacother 2012;13:1873-83.
7. Cea G, Benatar M, Verdugo RJ, Salinas RA. Thymectomy for nonthymomatous myasthenia gravis. Cochrane Database Syst Rev 2013;10: CD008111.
8. Wolfe GI, Kaminski HJ, Jaretzki A III, Swan A, Newsom-Davis J. Development of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapy. Ann N Y Acad Sci 2003;998:473-80.
9. Jaretzki A 3rd, Penn AS, Younger DS, Wolff M, Olarte MR, Lovelace RE et al. 'Maximal' thymectomy for myasthenia gravis. Results. J Thorac Cardiovasc Surg 1988;95:747-57.
10. Marulli G, Schiavon M, Perissinotto E, Bugana A, Di Chiara F, Rebusso A et al. Surgical and neurologic outcomes after robotic thymectomy in 100 consecutive patients with myasthenia gravis. J Thorac Cardiovasc Surg 2013;145:730-5; discussion 35-6.
11. Ruckert JC, Swierzy M, Ismail M. Comparison of robotic and nonrobotic thoracoscopic thymectomy: a cohort study. J Thorac Cardiovasc Surg 2011;141:673-7.
12. Jaretzki A 3rd, Sonett JR. Evaluation of results of thymectomy for MG requires accepted standards. Ann Thorac Surg 2007;84:360-1; author reply 61.
13. Keijzers M, Dingemans AM, Blaauwgeers H, van Suylen RJ, Hochstenbag M, Garsse L et al. 8 Years' experience with robotic thymectomy for thymomas. Surg Endosc 2014;28:1202-8.
14. Masaoka A, Yamakawa Y, Niwa H, Fukai I, Kondo S, Kobayashi M et al. Extended thymectomy for myasthenia gravis patients: a 20-year review. Ann Thorac Surg 1996;62:853-9.
15. Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg 2000;70:327-34.
16. Ismail M, Swierzy M, Ruckert JC. State of the art of robotic thymectomy. World J Surg 2013;37:2740-6.
17. Freeman RK, Ascioti AJ, Van Woerkom JM, Vyverberg A, Robison RJ. Long-term follow-up after robotic thymectomy for nonthymomatous myasthenia gravis. Ann Thorac Surg 2011;92:1018-22; discussion 22-3.
18. Spillane J, Hayward M, Hirsch NP, Taylor C, Kullmann DM, Howard RS. Thymectomy: role in the treatment of myasthenia gravis. J Neurol 2013; 260:1798-801.
19. Kattach H, Anastasiadis K, Cleuziou J, Buckley C, Shine B, Pillai R et al. Transsternal thymectomy for myasthenia gravis: surgical outcome. Ann Thorac Surg 2006;81:305-8.
20. Michels M, Hohlfeld R, Hartung HP, Heininger K, Besinger UA, Toyka KV. Myasthenia gravis: discontinuation of long-term azathioprine. Ann Neurol 1988;24:798.
21. Yamada Y, Yoshida S, Suzuki H, Tagawa T, Iwata T, Mizobuchi T et al. Efficacy of perioperative high-dose prednisolone therapy during thymectomy in myasthenia gravis patients. J Cardiothorac Surg 2013;8: 226.
22. Park IK, Choi SS, Lee JG, Kim DJ, Chung KY. Complete stable remission after extended transsternal thymectomy in myasthenia gravis. Eur J Cardiothorac Surg 2006;30:525-8.
23. Minnich DJ, Bryant AS, Cerfolio RJ. Thoracoscopic and robotic dissection of mediastinal lymph nodes. Thorac Surg Clin 2012;22:215-8.
24. Meraouna A, Cizeron-Clairac G, Panse RL, Bismuth J, Truffault F, Tallaksen C et al. The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood 2006;108:432-40.